🇺🇸 FDA
Patent

US 10400029

Serpin fusion polypeptides and methods of use thereof

granted A61KA61K38/00

Quick answer

US patent 10400029 (Serpin fusion polypeptides and methods of use thereof) held by Inhibrx, Inc. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00